EGFR transactivation in the regulation of SMC function

Annals of the New York Academy of Sciences

Volumn 947, Issue , 2001, Pages 42-55

  Kalmes, Andreas ^a   Daum, Günter ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor receptors; Platelet derived growth factor; Smooth muscle cells; Transforming growth factor alpha

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR;

ARTERY INJURY; ARTERY INTIMA PROLIFERATION; CELL ACTIVATION; CELL FUNCTION; CELL GROWTH; CONFERENCE PAPER; HUMAN; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

EID: 0035680293     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03929.x     Document Type: Conference Paper

References (90)

1. Vascular response to injury
2. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor
3. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor
4. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor
5. Response of the arterial wall to injury and intimal hyperplasia
6. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries
7. Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointima formation after arterial injury
8. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury
9. Antibody to thrombin receptor inhibits neointimal smooth muscle cell accumulation without causing inhibition of platelet aggregation or altering hemostatic parameters after angioplasty in rat
10. PDGF ligand and receptor gene expression during repair of arterial injury
11. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
12. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury
13. PDGF beta receptor blockade inhibits intimal hyperplasia in the baboon
14. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
15. EGF receptor
16. LET-23-mediated signal transduction during Caenorhabditis elegans development
17. Effect on eye development of dominant mutations in Drosophila homologue of the EGF receptor
18. A thousand and one roles for the Drosophila EGF receptor
19. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
20. Strain-dependent epithelial defects in mice lacking the EGF receptor
21. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
22. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
23. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene
24. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
25. The biology of erbB-2/neu/HER-2 and its role in cancer
26. Epidermal growth factor-related peptides and their receptors in human malignancies
27. The c-erbB3/HER3 receptor in human cancer
28. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis
29. Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa
30. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury
31. Involvement of the epidermal growth factor receptor in epithelial repair in asthma
32. The epidermal growth factor receptor and its ligand family: Their potential role in repair and remodelling in asthma
33. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing
34. Membrane-anchored growth factors
35. Control of EGF receptor signalling: Lessons from fruitflies
36. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
37. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
38. Cell growth control by G protein-coupled receptors: From signal transduction to signal integration
39. G-protein-coupled receptors and their regulation: Activation of the MAP kinase signaling pathway by G-protein-coupled receptors
40. Ras-dependent mitogen-activated protein kinase activation by G protein- coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase
41. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
42. Signal characteristics of G protein-transactivated EGF receptor
43. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation
44. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
45. Endothelin-1 stimulates DNA synthesis of vascular smooth-muscle cells through transactivation of epidermal growth factor receptor
46. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor
47. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
48. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor
49. Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells
50. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF
51. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells
52. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells
53. Heparin-binding EGF-like growth factor
54. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity
55. Activation of MAP kinases by angiotensin II in vascular smooth muscle cells: Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAP kinase, but not for JNK
56. Heparin-binding EGF-like growth factor: A juxtacrine growth factor
57. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor
58. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity
59. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
60. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
61. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer
62. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells
63. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor
64. Transactivation of the EGF receptor mediates IGF-1 stimulated Shc posphorylation and ERK1/2 activation in COS-7 cells
65. Signaling by the cytokine receptor superfamily
66. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
67. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells
68. Integrins and signal transduction pathways: The road taken
69. Integrins, angiogenesis and vascular cell survival
70. Integrin signaling
71. Signaling by integrin receptors
72. Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin
73. Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor
74. Integrin alpha5/betal mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation
75. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth
76. Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival
77. Integrin (&agr;)2(&bgr;)1-dependent EGF receptor activation at cell-cell contact sites
78. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques
79. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis
80. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue
81. Expression of heparin-binding epidermal growth factor-like growth factor in neointimal cells induced by balloon injury in rat carotid arteries
82. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: Possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation
83. Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor
84. Thrombin aivation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor
85. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation
86. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway
87. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho
88. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor
89. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity
90. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion